Title: Study of prevalence of hepatitis C among replacement donors versus voluntary donors in Tertiary care Hospital

Authors: Dr Ashok Yadav, Dr Priyanka Solanki, Dr Amrita Tripathi

 DOI:  https://dx.doi.org/10.18535/jmscr/v6i4.129

Abstract

Introduction: Hepatitis C infection is a major global health problem, which could easily lead to chronic liver disease, cirrhosis and even hepatocellular carcinoma.  The rapid global spread of HCV is believed to have occurred primarily because of efficient transmission through blood transfusion and parenteral exposures with contaminated equipment\

Materials and Methods: This study was carried out at the Blood bank, Department of Pathology M.Y. Hospital Indore. A retrospective review of 77108 donors over a period of 2 years (2015- 2017) was carried out. All individuals who presented themselves for blood donation during this period were included in the study. Screening of the donors was done with rapid test kit as well as ELISA The data were collated and analysed with SPSS version 20. Prevalence of HCV antibodies was expressed in percentages. Associations of HCV seropositivity with demography,

Results: A total of 77108 donors presented themselves for blood donation during the study period, Out of these 8.92%(6883) were replacement donors while 91.07% (70225) were voluntary donors. Among voluntary donors 0.01%(11) and among replacement donors 0.03%(29)  were reactive to HCV antibody . Donor with PCV value between 34-42% had highest HCV infection.

Conclusion: In conclusion, the frequency of active infection of HCV amongst the blood The seroprevalence of Hepatitis C virus infection in the study centre is 0.04 %.  This is considerably low percentage while keeping in view the previous publicized rates. Application of strict measures during blood donor selection and use of proper screening essay such as ELISA.

References

  1. Prati D: Transmission of hepatitis C virus by blood transfusions and othermedical procedures: a global review. J Hepatol 2006, 45:607-16.
  2. Chen YT, Jiang JJ: Epidemic situation of hepatitis C virus. Strait Journal of Preventive Medicine 2009, 15:19-21, [in Chinese].
  3. Abdul Majeed Akhtar, M. Athar Khan, TayyabaIjaz, Zafar Iqbal, Muhammad Younus, Rana, AzharMaqbool and Abdul Rehman.Seroprevalence and Determinants of Hepatitis-C Virus Infection in Blood Donors of Lahore, Pakistan. Pakistan J. Zool., vol.45(1), pp. 1-7, 2013.
  4. Soheir AE et al. Prevalence of anti-HIV, HBsAg and anti-HCV 13 reactivity in different categories of Egyptian blood donors:experience of the National Cancer Institute in the last 5 years. Journal of the Egyptian National Cancer Institute. 2002, (3):217–221.
  5. Ryas, M., Hussain, T., Bhatti, F.A., Ahmad, F,Tariq, W.U. And Khattack, M.F, Epidemiology of hepatitis C virus infection in blooddonors in Northern Pakistan. J. Rawalpindi med. Coll., 2001, 5: 56-59.
  6. Rehman, M.U., Akhtar, G.N. And Lodhi, Y, Seroprevalence of hepatitis C antibodies in blood donors. Pak. J. med. Sci., 2006.18:193-196.
  7. Asif, N., Kokhar, N. And Ilahi, F.,. Seroprevalence of HBV, HCV and HIV infection among voluntary non remunerated andreplacement donors in Northern Pakistan. Pak. J. med. Sci. 2004 20: 24-8.
  8. Farooqi, J.I., Farooqi, R.J. And Khan, N.M., Frequency of hepatitis B and C in selected groups of populations in NWFP, Pakistan.J. Postgrad. med. Ins., 2007. 21: 165-168
  9. Booth, J.C., 1998. Chronic hepatitis C: the virus, its discovery and natural history of the disease. J. Viral Hepatitis, 5: 213-22.
  10. Halim, N.K. and O.I. Ajayi, 2000. Risk factors and seroprevalence hepatitis C antibody in blood donors in Nigeria. East AfricanMedical J., 77: 410-12.
  11. Alao OO, Okwori EE, Araoye MO. The sero-prevalence of hepatitis C virus infection among prospective blood donors inMakurdi, Nigeria. The internet J. infect. 2010. Dis. 8: DOI: 10.5580/1d2e.
  12. Fathi Abed Al-Gani, Rashed Ben Al-Hassan Prevalence of HBV, HCV and HIV-1, 2 infections among blood donors in PrinceHospital in North Region of Jordan. Int J Biol Med Res. 2011; 2(4): 912 – 916
  13. Mehdi SR, Pophali A, Al-Abdulrahim KA. Prevalence of hepatitis B and C among blood donors. Saudi Med J. 2000; 21: 942-944.
  14. Nanu A, Sharma SP, Chatterjee K, Jyoti P. Markers for transfusion transmissible infections in North Indian voluntary andreplacement blood donors. Prevalence and Trends. 1989-1996. Vox Sang 1997; 73:70-73.
  15. Darwish MA, Raouf TA, Rushdy P, Constantine NT, Rao MR, Edelman R. Risk factors associated with a high seroprevalence ofhepatitis C virus infection in Egyptian blood donors. Am J Trop Med Hyg. 1993; 49: 440-447
  16. Othman BM, Monem FS. Prevalence of hepatitis C virus antibodies among intravenous drug abusers and prostitutes in Damascus,Syria. Saudi Med J. 2002; 23: 393-395.
  17. Gurol E. Trends in hepatitis B and hepatitis C virus among Blood donors over 16 years in Turkey. European Journal ofEpidemiology,2006, 21:299–305.
  18. Bala JA, Kawo AH, Muktar MD, Sark A, Magaji W, Aliyu LA, Sani MA. Prevalence of hepatitis C infection among blood donorin some selected hospitals in Kano, Nigeria. Intern. Res. J. Microbiol.2012 3: 217-22
  19. Glynn SA, Kleinman SH, et al. Trends in incidence and prevalence of major transfusion-transmissible viral infections in US blooddonors, 1991 to 1996. JAMA 2000; 284:2:229-235
  20. Vivas-Arceo C, Benavides SA, et al. Hepatitis C virus: prevalence and routes of infection among blood donors of West Mexico.Hepatology Research 2003; 25:115-123
  21. Tanim H, Irani-Hakime N, et al. Seroprevalence of Hepatitis C virus (HCV) infection among blood donors: a hospital-based study.Transfusion and Apheresis Science 2001; 24: 29-35
  22. Luksamijarulkul P, Thammata N, Tiloklurs M. Seroprevalence of hepatitis B, hepatitis C and human immunodeficiency virusamong blood donors, Phitsanulok regional blood center, Thailand. Southeast Asian J TropMed Public Health 2002. 33:272-9.
  23. Prevalence of hepatitis b and hepatitis cIn blood donors of Karachi. E:/Biomedica Vol.24, Jul. – Dec. 2008/Bio-9.Doc (WC) P.116-117
  24. Ahmed J. Frequency of Hepatitis B and C in Healthy blood donors of NWFP: a single center experience. J. Post Grad. Med. Inst. 2004; 18 (3): 343-52.
  25. Ishtiaq A.C. et al. Seroprevalence of Hepatitis B and C among the healthy donors at Fauji Foundation Hospital, Rawalpindi. Pak. J. Med. Sci. 2007; 23
  26. Epidemiology, biostatistics and preventive medicine, 2nd ed. Philadelphia, WB Saunders, 2001

Corresponding Author

Dr Priyanka Solanki

Add.-132 Ahilya Nagar Ext., Near Annapurna Indore Pin 452001

Email: This email address is being protected from spambots. You need JavaScript enabled to view it., Contact number-9977141298